How is poorly differentiated adenocarcinoma treated?

How is poorly differentiated adenocarcinoma treated?

In one report, 20 patients under the age of 61 with poorly differentiated adenocarcinoma or poorly differentiated carcinoma were treated with high dose chemotherapy, hematopoietic progenitor cells and growth factor support . There was only one complete response and overall median survival was 11 months.

Can poorly differentiated adenocarcinoma be cured?

It is now clear that some patients with poorly differentiated carcinoma of unknown primary site have extremely responsive neoplasms, and some are curable with combination chemotherapy.

What does poorly differentiated adenocarcinoma mean?

In other words, it relates to how abnormal your cancer cells look under a microscope. Well-differentiated adenocarcinoma is considered low grade. This type of cancer tends to grow and spread slower. Poorly differentiated adenocarcinoma is considered high grade because it usually spreads faster.

What stage is poorly differentiated adenocarcinoma?

Grade 3: Cancer cells and tissue look very abnormal. These cancers are considered poorly differentiated, since they no longer have an architectural structure or pattern. Grade 3 tumors are considered high grade.

What is survival rate of poorly differentiated carcinoma?

The median survival time was 43 months. Sixteen patients survived for more than 10 years (maximum 297 months). The five- and 10-year cause specific survival rates for Stages I, II, III and IV disease were 100 and 100%, 80 and 27%, 83 and 83%, and 38 and 31%, respectively.

How many types of carcinoma are there?

There are three major types of carcinoma, including adenocarcinoma, basal cell carcinoma, and squamous cell carcinoma.

Does adenocarcinoma respond to chemo?

Unfortunately, small intestine adenocarcinoma does not seem to be very sensitive to chemo, so it is not often part of the main treatment for this cancer. Still, it may be used in some situations: If the cancer has spread (metastasized) to other parts of the body.

When is combination chemotherapy indicated in the treatment of adenocarcinoma?

At present, a trial of combination chemotherapy should be considered for most patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site.

What is the prevalence of poorly differentiated adenocarcinoma?

Patients with poorly differentiated carcinoma account for approximately 20% of patients with carcinoma of unknown primary site; an additional 10% of patients have poorly differentiated adenocarcinoma.

What can I do to prevent adenocarcinoma?

Maintain a healthy weight. Eat a well-balanced diet. Visit your healthcare provider regularly. Is adenocarcinoma fatal? Adenocarcinoma prognosis varies depending on the type, location and size of the tumor. Cancers that are difficult to diagnose in the early stages are likely to be more fatal than cancers that are detectable early on.

Is poorly differentiated carcinoma of unknown primary site curable?

It is now clear that some patients with poorly differentiated carcinoma of unknown primary site have extremely responsive neoplasms, and some are curable with combination chemotherapy.